Antiepileptic Drugs (AEDs) Market Trends 2021 | Segmentation, Outlook, Industry Report to 2027
The global antiepileptic drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Antiepileptic drugs (AEDs) are commonly known as anticonvulsants or antiseizure drugs. These drugs are used in the treatment of epileptic seizures. Epilepsy is a central neurological disorder that causes brain activity to become abnormal and further causes seizures or periods of unusual behaviour, sensations and sometimes loss of awareness. Additionally, these drugs are also used to stabilize the mood along with the treatment of bipolar disorders or neuropathic pain.
To Request a Sample of our Report on Antiepileptic Drugs
(AEDs) Market: https://www.omrglobal.com/request-sample/antiepileptic-drugs-aeds-market
Some major key players in the market include Abbott
Laboratories, GlaxoSmithKline plc, and Pfizer Inc., among others. The market
players are contributing significantly to the growth of the market by the
adoption of various strategies including mergers & acquisitions,
geographical expansion, partnerships and collaborations, and new product
launches, to stay competitive in the market. For instance, in January 2022, Sun
Pharmaceutical Industries Ltd. announced the launch of a range of Brivaracetam
dosage forms at an affordable price for epilepsy treatment in India.
Additionally, in June 2021, Glenmark Pharma announced the launch of the
anti-epileptic drug, Rufinamide tablets in the US market. Furthermore, in March
2021, Alkem Laboratories has announced the launch of Brivasure, an affordable
anti-epileptic drug for the treatment of epilepsy in India.
Market
Coverage
• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered-
·
By Drug Type
• Regions Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
•
Competitive Landscape- Abbott
Laboratories, GlaxoSmithKline plc, and Pfizer Inc., among others.
(Get 15% Discount on Buying this Report)
A
full Report of Antiepileptic Drugs (AEDs) Market is Available @ https://www.omrglobal.com/industry-reports/antiepileptic-drugs-aeds-market
Global Antiepileptic Drugs Market Report by Segment
By
Drug Type
• First Generation AEDs
·
Phenytoin (Dilantin, Phenytek)
·
Carbamazepine (Carbatrol)
·
Oxycarbazepine (Trileptal)
·
Valproate (Depakote)
·
Others
• Second Generation AEDs
·
Lamotrigine (Lamictal)
·
Pregabalin (Lyrica)
·
Rufinamide (Banzel/Inovelon)
·
Levetiracetam (Keppra)
·
Others
Global
Antiepileptic Drugs Market Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other research-based
services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment